The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Accelerate Diagnostics's current ratio for the quarter that ended in Dec. 2024 was 0.71.
Accelerate Diagnostics has a current ratio of 0.71. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Accelerate Diagnostics has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Accelerate Diagnostics's Current Ratio or its related term are showing as below:
AXDXQ'
s Current Ratio Range Over the Past 10 Years
Min: 0.71 Med: 13.35 Max: 25.28
Current: 0.71
During the past 13 years, Accelerate Diagnostics's highest Current Ratio was 25.28. The lowest was 0.71. And the median was 13.35.
AXDXQ's Current Ratio is ranked worse than 91.21% of 865
companies
in the Medical Devices & Instruments industry
Industry Median: 2.55
vs AXDXQ: 0.71
Accelerate Diagnostics Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Accelerate Diagnostics's Current Ratio
For the Medical Devices subindustry, Accelerate Diagnostics's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accelerate Diagnostics's Current Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Current Ratio distribution charts can be found below:
* The bar in red indicates where Accelerate Diagnostics's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accelerate Diagnostics (OTCPK:AXDXQ) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Accelerate Diagnostics Current Ratio Related Terms
Thank you for viewing the detailed overview of Accelerate Diagnostics's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AXDXQ has been successfully added to your 